Cerus Corp
Cerus Corp (CERS) Straddle
CERS straddle scan found 2 qualifying long straddle setups on the previous trading day. Probability of profit reaches up to 60.0%.
Read more
Trading a CERS straddle lets you take a pure volatility position on Cerus Corp without committing to a direction. Cerus Corp's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate CERS straddle pricing in real time and find the moments when expected moves are mispriced.
A long straddle on CERS profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when Cerus Corp stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the CERS straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion; and INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma, cryoprecipitate reduced.
It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. The company was incorporated in 1991 and is headquartered in Concord, California.
Earnings, product cycles, macro prints — any time volatility itself is the trade, the CERS straddle is the cleanest expression of that view. Our scanner prices every CERS straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a CERS straddle into a catalyst or short a CERS straddle to harvest decay, the options straddle setups that matter are all in one place.
| Feb 19, 2027 | 3.00 | $1.05 | 156 | 10% | 60.0% | $4.05 | $1.95 | 170 |
| Feb 19, 2027 | 5.00 | $3.00 | 156 | 10% | 48.3% | $8.00 | $2.00 | 0 |
As of September 17, 2026
Find the right straddle before volatility moves
Track CERS straddle pricing across expirations, filter by IV rank and breakeven points, and build a setup that fits your view before the move happens.
Start your 14-day free trial→